z-logo
open-access-imgOpen Access
How to make a better T cell: in vivo CRISPR screens have some answers
Author(s) -
Matteo Villa,
Michal A. Stanczak,
Erika L. Pearce
Publication year - 2021
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2021.02.003
Subject(s) - biology , crispr , in vivo , cell , cd8 , t cell , immunity , computational biology , genome editing , microbiology and biotechnology , genetics , immune system , gene
Understanding what regulates CD8 + T cell responses is key to effectively harnessing these cells in human disease. In this issue of Cell, Huang et al. and Chen et al. use in vivo CRISPR screens to discover novel regulators of CD8 + T cell immunity to engineer a more efficacious response against cancer and infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom